3-rx.comCustomer Support
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics

\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>

Join our Mailing List


You are here : 3-RX.com > Home > Skin Care -

Few patients on steroids receive bone-saving drugs

Skin CareJan 18, 06

Contrary to the guidelines of the American College of Rheumatology (ACR), patients on long-term steroid treatment are often not prescribed therapy to prevent the bone-thinning disease osteoporosis, according to findings from a small study.

Steroids are commonly prescribed for chronic skin diseases and “autoimmune” conditions in which the body attacks itself. “Patients receiving long-term corticosteroid therapy have an increased risk of developing osteoporosis,” said Dr. Victoria P. Werth of the Veterans Administration Hospital in Philadelphia.

“In the last 10 years, the literature has produced very good guidelines for how to try to prevent osteoporosis, but I’m aware of the fact that in any community, not just dermatology, the guidelines are not being followed very carefully,” Werth said. The ACR guidelines recommend so-called bisphosphonate drugs (Fosamax is an example) for all patients beginning long-term steroid treatment.

Werth and her colleagues studied 35 patients with chronic skin disease who were taking the steroid prednisone for at least a month. The researchers evaluated the use of bisphosphonates through medical chart reviews and communication with the patients.

As they report in the Archives of Dermatology, the researchers found that 28 of the 35 patients were not receiving bisphosphonates and the proportion of patients on preventive treatment didn’t change after the ACR guidelines were published.

“Many papers show that bisphosphonates maintain or even increase bone (thickness) and that they decrease the number of fractures,” Werth said. “Bisphosphonates work. This study was really an effort to increase awareness among dermatologists that they need to follow the guidelines.”

SOURCE: Archives of Dermatology, January 2006.

Print Version
comments powered by Disqus

  Gene may open door for improved keloid, scar treatment
  Men, boomers fuel growth in spa industry
  Stick-on tattoos go electric
  Cell binding discovery brings hope to those with skin and heart problems
  Features of the metabolic syndrome common in persons with psoriasis
  Artificial “skin” materials can sense pressure
  2010 “Suntelligence: How Sun Smart is Your City?” Fact Sheet
  Association Discovered Between Eczema in Early Childhood and Psychological Problems
  Psoriasis treatment may up cancer risk
  Severe Cases of Psoriasis Can be Associated with Other Serious Medical Conditions
  Investigational study of ustekinumab in the treatment of psoriatic arthritis published
  TNF-blocker therapy for RA may trigger psoriasis


Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site